Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien 
Portrait de Jeffrey S. Aronin
Alter : 53
Vermögen : 12 696 465 USD
Größte Unternehmen : Discover Financial Services - Harmony Biosciences Holdings, Inc.
Übersicht 
Jeffrey S. Aronin is an entrepreneur and businessperson who founded 8 companies, among them: Harmony Biosciences Holdings, Inc., OVATION Pharmaceuticals, Inc. and Paragon Biosciences LLC and who has been the head of 10 different companies. Presently, Mr. Aronin holds the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Co-Chairman for MATTER Chicago (which he founded), Non-Executive Chairman for Harmony Biosciences Holdings, Inc. (which he founded in 2017), Chairman & Chief Executive Officer at Paragon Biosciences LLC (which he founded in 2010), Chairman & Chief Executive Officer of Emalex Biosciences, Inc. (which he founded), Chairman of Castle Creek Biosciences, Inc. (which he founded in 2018) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Jeffrey S. Aronin is also on the board of 13 other companies.

In the past he was Chairman & Chief Executive Officer of Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer of Enterprise Technologies, Inc., President & Chief Executive Officer at OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer at Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

Jeffrey S. Aronin received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Aktuelle Stellungen und Verantwortungsbereiche Jeffrey S. Aronin 
NameTitel Seit
Discover Financial Services
(Banken)
Independent Director 2008
Harmony Biosciences Holdings, Inc.
(Pharmazeutika)
Non-Executive Chairman 2017
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Castle Creek Biosciences, Inc. Chairman 2018
MATTER Chicago Co-Chairman -
CIRC Biosciences, Inc. Director -
The University of Chicago Medical Center Director -
Skyline Biosciences LLC Director -
Qlarity Imaging LLC Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Paragon Biosciences Emalex Capital, Inc. Director -
Harmony Biosciences LLC Director -
Castle Creek Biosciences LLC Director 2015
Ravinia Festival Association Trustee -
Pharmaceutical Research & Manufacturers of America Director 2010
The Commercial Club of Chicago Director -
The Aspen Institute, Inc. Director -


Anteile an Jeffrey S. Aronin 
NameAktien%Bewertung
Harmony Biosciences Holdings, Inc. (HRMY)
(Pharmazeutika)
251 9220,43%11 061 895 USD
Discover Financial Services (DFS)
(Banken)
16 2660,0060%1 634 570 USD


Jeffrey S. Aronin: Persönliches Netzwerk 
Meistgelesene News 
29.09.Buffetts Berkshire Hathaway kauft 5,99 Mio. weitere Occidental-Aktien
MR
26.09.Die Seifenoper von Unilever: M&A, Stellenabbau, Nelson Peltz im Vorstand
MR
30.09.Bei Fresenius und Dialysetochter FMC startet am Samstag neue Führunsspitze
DP
05.10.Musk sagt, der Twitter-Deal sei ein "Beschleuniger" für die Entwicklung einer "Alles-App".
MR
26.09.Twitter interviewt Elon Musk, der für seine kämpferischen Äußerungen bekannt ist
MR
21.09.Prozess gegen Trump-Verbündeten Barrack wegen ausländischer Agenten beginnt mit den Eröffnungsplädoyers
MR
28.09.Elon Musk will SEC-Zustimmung einschränken, Vorabgenehmigung von Tweets beenden
MR
29.09.Der lange, kurvenreiche Weg zum Porsche-Börsengang von Volkswagen
MR
04.10.Kreml findet Musk-Vorstoß 'positiv' - weist ihn aber im Kern zurück
DP
21.09.Bloomberg will 85 Millionen Dollar gegen den Ausbau von Plastik und Petrochemie in den USA ausgeben
MR
Mehr Börsen-Nachrichten, Aktienanalysen und Empfehlungen


© 2022 People and Ownership :   
Jeffrey S. Aronin : Verbindungen